case_images: PMC10578053_01
case_images: Case 1: CRP course during the disease duration and antiviral treatment.
case_images: UJMS-128-9807-g001.jpg
case_images: PMC10578053_01_UJMS-128-9807-g001.jpg
case_images: F0001
case_images: After 5 days of treatment, CRP was normal (Figure 1), and the patient felt relief from the clinical symptoms.
case_images: CT scans of Case 1 in (a) June, (b) August, and (c) October, demonstrating a pattern interpreted as organizing pneumonia that initially progressed and then regressed after antiviral treatment.
case_images: UJMS-128-9807-g005.jpg
case_images: PMC10578053_01_UJMS-128-9807-g005.jpg
case_images: F0005
case_images: This image was consistent with a pattern of organizing pneumonia (OP) (Figure 5a), which gave rise to interdisciplinary discussions on whether this was an infectious condition or an interstitial lung disease associated with her MCTD (MCTD-ILD). Clinic because of persistent symptoms of high fever, effort dyspnea, cough, and fatigue. CRP was now 62 mg/L, and a new chest CT scan revealed progress of OP (Figure 5b). A follow-up CT scan was performed 2 months later, showing regression of earlier pulmonary infiltrates (Figure 5c), and the patient self-reported resolution of all symptoms.
case_images: PMC10578053_02
case_images: Case 2: CRP course during the disease duration and antiviral treatment.
case_images: UJMS-128-9807-g002.jpg
case_images: PMC10578053_02_UJMS-128-9807-g002.jpg
case_images: F0002
case_images: After 5 days, CRP was almost normal (Figure 2) and the patient was discharged. At the most recent follow-up (i.e. 6 months after discharge), the patient was still feeling well and reported resolution of all symptoms (Figure 2).
case_images: PMC10578053_03
case_images: PMC10578053_04
case_images: Case 4: CRP course during the disease duration and antiviral treatment.
case_images: UJMS-128-9807-g004.jpg
case_images: PMC10578053_04_UJMS-128-9807-g004.jpg
case_images: F0004
case_images: After the remdesivir treatment, the fever and respiratory symptoms resolved and CRP decreased to 50 mg/L (Figure 4).